Contribution: Industrial Research Assistance Program – Contributions to Firms
Reya Health Inc.
$40,150.00
Product Commercialization Research
FY 2023-24 · 2023-05-01
Summary
Deploy MVP mobile app to test clients and collect feedback for product refinement. Also develop a commercialization plan based upon market response to application.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
London|London, Ontario, Canada
Recipient Type
For-profit organization
Business Number
722010139
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-05-01 | 2023-24 | $25,150.00 |
| 1 | 2023-05-01 | 2023-24 | $40,150.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days. The total amended value is 15,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 60 jours. La valeur totale des modifications est de 15 000 dollars.
Agreement End Date
2024-03-31
Agreement Number
1008472
Agreement Start Date
2023-05-01
Agreement Title
Product Commercialization Research
Agreement Title (French)
Recherche sur la commercialisation des produits
Agreement Type
Contribution
Agreement Value
$40,150.00
Amendment Date
2023-12-11
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Deploy MVP mobile app to test clients and collect feedback for product refinement. Also develop a commercialization plan based upon market response to application.
Description (French)
Déployer l’application mobile PMV pour tester les clients et recueillir des commentaires pour affiner le produit. Élaborer également un plan de commercialisation basé sur la réponse du marché à l’application.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Lambton--Kent--Middlesex
Federal Riding (French)
Lambton--Kent--Middlesex
Federal Riding Number
35048
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
722010139
Recipient City
London|London
Recipient Country
CA
Recipient Legal Name
Reya Health Inc.
Recipient Operating Name
Reya
Recipient Postal Code
N5X 4B2
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2023-2024-Q2-1008472
